ClinicalTrials.gg
WithdrawnNCT04569708Updated Nov 13, 2026

Sleep Spindles and Memory in Rolandic Epilepsy

An interventional study of Closed loop auditory stimulation in Rolandic Epilepsy, Rolandic Epilepsy, Benign and Centrotemporal Epilepsy, sponsored by Massachusetts General Hospital. Withdrawn at 1 site in United States. Open to participants aged 4 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Basic science

How we know

Why this study was withdrawn
Subjects were never enrolled and PI moved
Updated Nov 13, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
4 Years to 18 Years
Sex
All
01

Study summary

The investigators are recruiting children with Rolandic epilepsy and children without epilepsy (aged 4 years old and above) for a non-invasive brain imaging study using Magnetic Resonance Imaging (MRI), Magnetoencephalography/Electroencephalography (MEG/EEG), and experimental tasks. The investigators hope to determine the brain circuits and brain rhythms affected in these children and ultimately identify new treatment options for childhood epilepsy patients.

Read the detailed description

This is a prospective study of epilepsy biomarkers in a total of 100 subjects of ages 4-18. Participants will spend about 5 hours at the Massachusetts General Hospital (MGH) Athinoula A. Martinos Center for Biomedical Imaging. They will undergo training on a memory task concurrent with EEG/MEG recordings. During the EEG, subjects will wear headphones that will deliver a quiet pink noise stimulus intermittently during a nap, or a sham. The auditory stimulus will be calibrated in volume to not cause arousals. After napping, subjects will undergo cognitive testing and memory task testing.

02

Conditions studied

  • Rolandic Epilepsy
  • Rolandic Epilepsy, Benign
  • Centrotemporal Epilepsy
  • Centrotemporal; EEG Spikes, Epilepsy of Childhood
  • Epilepsy; Seizure
  • Epilepsy
03

In context

Epilepsy, Rolandic

23 studies on the registry are indexed under Epilepsy, Rolandic; 3 are open to participants now.

Browse Epilepsy, Rolandic studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,591 studies on the registry; 445 are open to participants now.

Of its 224 completed or terminated interventional studies of FDA-regulated products, 168 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of childhood epilepsy with centrotemporal spikes (CECTS)or Rolandic epilepsy by child neurologist
  • Ages 4-18 years
  • Has an EEG with sleep activated centrotemporal spikes
  • Has had at least 1 focal motor or generalized seizure

Exclusion criteria

Exclusion Criteria:

  • Has abnormal brain MRI
  • Has other unrelated neurological disease
  • Unable to have an MRI/MEG due to claustrophobia, history of frequent vomiting, permanent metal in body (braces), or over MRI weight limit: 350lbs
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Closed loop auditory stimulation Children and adolescents with epilepsy and controls

    Closed loop auditory stimulation during nap

    Other: Closed loop auditory stimulation

Interventions

  • OtherClosed loop auditory stimulation

    Quiet auditory stimulation timed with sleep physiology

06

What researchers measure

Primary outcomes

  1. Spindle Density

    Spindle count per minute during non-rapid eye movement (NREM) sleep

    Time frame: 1-5 hours

  2. Memory performance

    Percent improvement in memory task performance

    Time frame: 1-5 hours

Other outcomes

  1. Spindle-slow oscillation coupling

    Cross frequency coupling

    Time frame: 1-5 hours

07

Study locations

1 site
  • Athinoula A. Martinos Center Biomedical Imaging
    Charlestown, Massachusetts 02129, United States
08

References and documents

Individual participant data

Plan to share: Yes — Derivative data will be shared with appropriate IRB approval per publication requirements

Supporting information: Analytic code

Time frame: 2020 - 2030

Access criteria: In accordance with IRB approval

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jan 2021 (actual). Primary completion is estimated for Dec 2099, 947 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Jun 2025 → Dec 2099 and completion Jun 2025 → Dec 2099.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 24, 2020
First posted
Sep 30, 2020
StartActual
Jan 16, 2021
Primary completionEst.
Dec 31, 2099was Jun 2025
CompletionEst.
Dec 31, 2099was Jun 2025
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 30, 2025→Dec 31, 2099
Nov 13, 2026
Study completion
Jun 30, 2025→Dec 31, 2099
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Primary completion Jun 30, 2025→Dec 31, 2099
    Study completion Jun 30, 2025→Dec 31, 2099
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04569708
Responsible party
Catherine Chu, MD (Principal Investigator, Massachusetts General Hospital) — Principal investigator
First posted
Sep 30, 2020
Start date
Jan 16, 2021
Primary completion
Dec 31, 2099 (estimated)
Completion
Dec 31, 2099 (estimated)
Last update
Nov 13, 2026

Study contacts

Catherine Chu, MD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion